<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T07:14:11Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/178839" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/178839</identifier><datestamp>2025-12-05T13:18:05Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478798</setSpec><setSpec>col_2072_478916</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:Item id="hdl_2445_178839">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:2445/178839</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants</dc:title>
               <dc:creator>Unhjem Wiik, Mariann</dc:creator>
               <dc:creator>Evans, Tiffany Jane</dc:creator>
               <dc:creator>Belhadj, Sami</dc:creator>
               <dc:creator>Bolton, Katherine A.</dc:creator>
               <dc:creator>Dymerska, Dagmara</dc:creator>
               <dc:creator>Jagmohan Changur, Shantie</dc:creator>
               <dc:creator>Capellá, G. (Gabriel)</dc:creator>
               <dc:creator>Kurzawski, Grzegorz</dc:creator>
               <dc:creator>Wijnen, Juul T.</dc:creator>
               <dc:creator>Valle, Laura</dc:creator>
               <dc:creator>Vasen, Hans</dc:creator>
               <dc:creator>Lubinski, Jan</dc:creator>
               <dc:creator>Scott, Rodney J.</dc:creator>
               <dc:creator>Talseth-Palmer, Bente A.</dc:creator>
               <dc:subject>Cancer</dc:subject>
               <dc:subject>Malalties hereditàries</dc:subject>
               <dc:subject>Factors de risc en les malalties</dc:subject>
               <dc:subject>Càncer</dc:subject>
               <dc:subject>Genetic diseases</dc:subject>
               <dc:subject>Risk factors in diseases</dc:subject>
               <dc:description>Individuals with Lynch syndrome (LS), have an increased risk of developing cancer. Common genetic variants of telomerase reverse transcriptase (TERT) have been associated with a wide range of cancers, including colorectal cancer (CRC) in LS. We combined genotype data from 1881 LS patients, carrying pathogenic variants in MLH1, MSH2 or MSH6, for rs2075786 (G>A, intronic variant), 1207 LS patients for rs2736108 (C>T, upstream variant) and 1201 LS patients for rs7705526 (C>A, intronic variant). The risk of cancer was estimated by heterozygous/homozygous odds ratio (OR) with mixed-effects logistic regression to adjust for gene/gender/country of sample origin considering family identity. The AA genotype of SNP rs2075786 is associated with 85% higher odds at developing cancer compared to GG genotype in MSH2 pathogenic variant carriers (p = 0.0160). Kaplan-Meier analysis also shows an association for rs2075786; the AA allele for MSH2 variant carriers confers risk for earlier diagnosis of LS cancer (log-rank p = 0.0011). We report a polymorphism in TERT to be a possible modifier of disease risk in MSH2 pathogenic variant carriers. The rs2075786 SNP in TERT is associated with a differential risk of developing cancer for MSH2 pathogenic variant carriers. Use of this information has the potential to personalise screening protocols for LS patients.</dc:description>
               <dc:date>2021-07-05T11:07:07Z</dc:date>
               <dc:date>2021-07-05T11:07:07Z</dc:date>
               <dc:date>2021-05-31</dc:date>
               <dc:date>2021-07-02T12:00:36Z</dc:date>
               <dc:type>info:eu-repo/semantics/article</dc:type>
               <dc:relation>Reproducció del document publicat a: https://doi.org/10.1038/s41598-021-90501-2</dc:relation>
               <dc:relation>Scientific Reports, 2021, vol. 11, num. 11401</dc:relation>
               <dc:relation>https://doi.org/10.1038/s41598-021-90501-2</dc:relation>
               <dc:rights>cc by (c) Unhjem Wiik, Mariann et al., 2021</dc:rights>
               <dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights>
               <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
               <dc:publisher>Springer Science and Business Media LLC</dc:publisher>
               <dc:source>Articles publicats en revistes (Ciències Clíniques)</dc:source>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>